15 Clinical outcomes in patients treated with glycoprotein IIB/IIIA inhibitors during primary percutaneous coronary intervention according to arterial access site

Arvindra Krishnamurthy; Claire Keeble; Michelle Anderson; Kathryn Somers; Natalie Burton-Wood; Charlotte Harland; Paul Baxter; James McLenachan; Jonathan Blaxill; Daniel Blackman; Christopher Malkin; Stephen Wheatcroft; John Greenwood

doi:10.1136/heartjnl-2018-BCS.15

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BCS

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Alerts

Acute Coronary Syndromes

15 Clinical outcomes in patients treated with glycoprotein IIB/IIIA inhibitors during primary percutaneous coronary intervention according to arterial access site

Log in using your username and password

Main menu

Log in using your username and password

You are here

Read the full text or download the PDF:

Log in using your username and password